Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.62 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.62 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.62 |
| ▸ | DHFR | P00374 | 1/20 | 0.62 |
| ▸ | MPO | P05164 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.62 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.62 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.62 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.62 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.62 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1922753 | 0.95 | LMNA (0.63) | RAPGEF4KMT2ALMNATDP1MEN1 | |
| SCHEMBL11403543 | 0.93 | KMT2A (0.61) | RAPGEF4KMT2ALMNATDP1MEN1 | |
| SCHEMBL1922752 | 0.87 | RAPGEF4 (0.59) | RAPGEF4KMT2ALMNATDP1MEN1 | |
| SCHEMBL30020305 | 0.84 | TDP1 (0.53) | RAPGEF4KMT2ALMNATDP1MEN1 | |
| SCHEMBL429858 | 0.84 | MEN1 (0.58) | RAPGEF4KMT2ALMNATDP1MEN1 | |
| SCHEMBL30594032 | 0.84 | MEN1 (0.58) | RAPGEF4KMT2ALMNATDP1MEN1 | |
| SCHEMBL9220029 | 0.83 | MAPT (0.61) | RAPGEF4KMT2ALMNATDP1MEN1 | |
| SCHEMBL23876456 | 0.83 | RAPGEF4 (0.50) | RAPGEF4KMT2ALMNATDP1MEN1 | |
| SCHEMBL2321360 | 0.83 | ALDH1A1 (0.55) | RAPGEF4KMT2ALMNATDP1MEN1 | |
| SCHEMBL1922114 | 0.82 | RAPGEF4 (0.53) | RAPGEF4KMT2ALMNATDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2797872-B1 | SULFIDE SCAVENGERS, METHODS FOR MAKING THEM AND METHODS FOR USING THEM | GEN ELECTRIC (US) | 2018-02-28 | — | — | EP | claimed |
| US-9108899-B2 | Sulfide scavengers, methods for making and methods for using | GENERAL ELECTRIC COMPANY (US) | 2015-08-18 | — | — | US | claimed |
| EP-2797872-A1 | SULFIDE SCAVENGERS, METHODS FOR MAKING AND METHODS FOR USING THEM | General Electric Company (US) | 2014-11-05 | — | — | EP | claimed |
| US-8530394-B2 | Sterically hindered N-methyl secondary and tertiary amine sulfur scavengers and methods for making and using same | CLEARWATER INTERNATIONAL LLC (US) | 2013-09-10 | — | — | US | claimed |
| US-20130172623-A1 | SULFIDE SCAVENGERS, METHODS FOR MAKING AND METHODS FOR USING | GENERAL ELECTRIC COMPANY (US) | 2013-07-04 | — | — | US | claimed |
| WO-2013101361-A1 | SULFIDE SCAVENGERS, METHODS FOR MAKING AND METHODS FOR USING THEM | GENERAL ELECTRIC COMPANY (US) | 2013-07-04 | — | — | WO | claimed |
| US-20090250659-A1 | STERICALLY HINDERED N-METHYL SECONDARY AND TERTIARY AMINE SULFUR SCAVENGERS AND METHODS FOR MAKING AND USING SAME | CLEARWATER INTERNATIONAL, LLC (US) | 2009-10-08 | — | — | US | claimed |
| US-20050153846-A1 | Sterically hindered N-methylsecondary and tertiary amine sulfur scavengers and methods for making and using same | WEATHERFORD/LAMB, INC. | 2005-07-14 | — | — | US | claimed |
| EP-4545620-A2 | ETHYLENE OLIGOMERIZATION PROCESSES | Chevron Phillips Chemical Company LP (US) | 2025-04-30 | — | — | EP | disclosed |
| CN-117616032-A | Rare earth complex | 东曹株式会社 | 2024-02-27 | — | — | CN | disclosed |
| EP-4319917-A2 | ETHYLENE OLIGOMERIZATION PROCESSES | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2024-02-14 | — | — | EP | disclosed |
| US-11873264-B2 | Ethylene oligomerization processes | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2024-01-16 | — | — | US | disclosed |
| US-11667590-B2 | Ethylene oligomerization processes | CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) | 2023-06-06 | — | — | US | disclosed |
| US-20230093448-A1 | ETHYLENE OLIGOMERIZATION PROCESSES | CHEVRON PHILLIPS CHEMICAL COMPANY, LP | 2023-03-23 | — | — | US | disclosed |
| US-6737193-B2 | ACTIVE MATERIALS IN THE POSITIVE ELECTRODES OF BATTERIES. NOVEL METHODS FOR PREPARING THE TETRAKETOPIPERAZINE UNIT-CONTAINING COMPOUNDS INCLUDE: (I) REACTING AN OXALYL HALIDE AND AN OXAMIDE, AND ADDING WATER OR AN AQUEOUS ALKALI | IM&T RESEARCH, INC. | 2004-05-18 | — | — | US | disclosed |
| WO-2004011692-A2 | PROCESS FOR PREPARING DIHYDROCARBYLAMINO METAL COMPOUNDS | ALBEMARLE CORPORATION (US) | 2004-02-05 | — | — | WO | disclosed |
| US-20030148188-A1 | Active materials in the positive electrodes of batteries. Novel methods for preparing the tetraketopiperazine unit-containing compounds include: (i) reacting an oxalyl halide and an oxamide, and adding water or an aqueous alkali | IM&T RESEARCH, INC. | 2003-08-07 | — | — | US | disclosed |
| US-20020048710-A1 | Electrophotographic photosensitive member, process cartridge, and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2002-04-25 | — | — | US | disclosed |
| US-4375560-A | Process for the preparation of 3,5-dimethylaniline (sym. m-xylidine) | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-03-01 | — | — | US | disclosed |
| US-4375561-A | Process for the preparation of aromatic amines | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130172623-A1 | SULFIDE SCAVENGERS, METHODS FOR MAKING AND METHODS FOR USING | CBS, TST, GSS | RAPGEF4 4616/4885KMT2A 3923/4885LMNA 3867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.